🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

16+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 16 recruiting trials for “intraductal-papillary-mucinous-carcinoma-of-pancreas”

RecruitingNCT07216521 ↗

Intent of Surgery for IPMN

👨‍⚕️ Greg Sacks, MD MPH PhD, NYU Langone Health📍 14 sites📅 Started Sep 2025View details ↗
RecruitingNCT07117045 ↗

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

🏥 Changhai Hospital📍 5 sites📅 Started Aug 2025View details ↗
RecruitingNCT06574373 ↗

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

👨‍⚕️ Carmine Carbone, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06694792 ↗

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

🏥 IRCCS San Raffaele📍 1 site📅 Started Jan 2025View details ↗
Enrolling by InvitationNCT06276764 ↗

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

👨‍⚕️ Gregory Haber, MD FRCP, Manhattan Endoscopy Center📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06638866 ↗

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

👨‍⚕️ Jin Gang, M.D., Changhai Hospital📍 3 sites📅 Started Aug 2024View details ↗
Enrolling by InvitationNCT06283576 ↗

Pancreatic Cancer Initial Detection Via Liquid Biopsy

🏥 Karolinska University Hospital📍 1 site📅 Started May 2024View details ↗
RecruitingNCT05433935 ↗

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

👨‍⚕️ Tingbo Liang, PhD, Zhejiang University📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05117723 ↗

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer

👨‍⚕️ Adrian Fox, St Vincent's Hospital Melbourne📍 1 site📅 Started Aug 2021View details ↗
Phase 2RecruitingNCT04858334 ↗

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

👨‍⚕️ Kim A Reiss Binder, ECOG-ACRIN Cancer Research Group📍 454 sites📅 Started Jun 2021View details ↗
Phase 1, PHASE2RecruitingNCT04657068 ↗

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

👨‍⚕️ Melissa Johnson, MD, Tennessee Oncology📍 79 sites📅 Started Jan 2021View details ↗
Phase 1RecruitingNCT04150042 ↗

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

👨‍⚕️ Arnold Glazier, M.D., General Oncology, Inc.📍 2 sites📅 Started Jan 2021View details ↗
RecruitingNCT06706700 ↗

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

🏥 IRCCS San Raffaele📍 1 site📅 Started Jul 2020View details ↗
RecruitingNCT04275557 ↗

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

👨‍⚕️ Jennifer Permuth, PhD, Moffitt Cancer Center📍 3 sites📅 Started Feb 2020View details ↗
RecruitingNCT03492151 ↗

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

👨‍⚕️ Somashekar Krishna, MD, MPH, Ohio State University📍 10 sites📅 Started Oct 2018View details ↗
NARecruitingNCT02757859 ↗

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

👨‍⚕️ Harish Lavu, MD, Thomas Jefferson University📍 2 sites📅 Started Apr 2016View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →